Valens Semiconductor Reports First Quarter 2025 Results
Key Financial Highlights:
- Q1 revenues:
$16.8 million , exceeding the top end of our guidance. - Q1 gross margin: 62.9% GAAP; 66.7% non-GAAP.
- Cash, cash equivalents and short-term deposits:
$112.5 million .
"Valens had a positive start to 2025," said
"We've rounded out the first quarter of 2025 having, once again, exceeded the top end of our revenue guidance," said
Q1 2025 Financial Highlights:
- Q1 revenues reached
$16.8 million , exceeding our guidance of$16.3-$16.6 million , compared to$16.7 million in Q4 2024 and$11.6 million in Q1 2024.
- Q1 Cross-Industry Business ("CIB") revenues, accounted for approximately 70% of total revenues at$11.7 million compared to$11.7 million dollars in Q4 2024 and$7.2 million in Q1 2024.
-Q1 Automotive revenues accounted for approximately 30% of total revenues at$5.1 million , compared to$5.0 million dollars in Q4 2024 and$4.4 million in Q1 2024. - Q1 GAAP gross margin was 62.9% (non-GAAP gross margin was 66.7%), above the guidance. This is compared to a GAAP gross margin of 60.4% for Q4 2024 and 59.0% for Q1 2024 (non-GAAP gross margin of 64.5% in Q4 2024 and 62.0% in Q1 2024). On a segment basis, Q1 gross margin from the CIB was 69.1% and gross margin from Automotive was 48.4%. This compares to a Q4 2024 gross margin of 64.7% and 50.5%, respectively, and a Q1 2024 gross margin of 77.2% and 29.1%, respectively. The increase in Q1 automotive gross margin compared to Q1 2024 was due to an optimization of our product cost. The increase in gross margin of the CIB compared to Q4 2024 was due to an inventory adjustment in Q4 2024.
- Q1 GAAP net loss amounted to
$(8.3) million , compared to a net loss of$(7.3) million dollars in Q4 2024 and a net loss of$(10.0) million dollars in Q1 2024. - Q1 adjusted EBITDA was a loss of
$(4.3) million , within the guidance range of$(4.5)-$(4.2) million EBITDA loss. This compares to an adjusted EBITDA loss of$(3.7) million dollars in Q4 2024 and an adjusted EBITDA loss of$(7.1) million dollars in Q1 2024. - Cash balance as of
March 31, 2025 , was$112.5 million . This compares to a cash balance of$131.0 million as ofDecember 31, 2024 . During the first quarter of 2025 the company used$9.6 million for the share repurchase programs, announced inDecember 2024 and inFebruary 2025 .
Q1 2025 Business Highlights:
- Received endorsement from Sennheiser for our extension technology to use with the company's TeamConnect Bar solutions
- Partnered with RGo Robotics and CHERRY Embedded Solutions to design optimized AI robotic systems
- In April, announced that Valens' VA7000 MIPI A-PHY-compliant chipsets will form the in-car, sensor to compute connectivity infrastructure for Mobileye EyeQ™6 High automated and autonomous production programs underway with a group of global automotive brands
- Successfully completed product interoperability testing with seven MIPI A-PHY silicon vendors to advance the standard ecosystem in
China and globally - Announced a new share repurchase program of
$15 million , which was launched onMarch 17, 2025 . During the first quarter of 2025 the company completed the first repurchase program of$10 million announced inDecember 2024
Financial Outlook for Q2 2025
For Q2 2025,
Disclaimer:
Conference Call Information
NYSE Rule 203.01 Annual Financial Report Announcement
Pursuant to Rule 203.01 of the New York Stock Exchange Manual,
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "estimate," "plan," "project," "forecast," "intend," "will," "expect," "anticipate," "believe," "seek," "target" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding our anticipated future results, including financial results, our five-year plan, currency exchange rates, and contract wins, and future economic and market conditions. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of
About Valens Semiconductor
SUMMARY OF FINANCIAL RESULTS
(
|
Three Months Ended
|
||
|
2025 |
2024 |
|
Revenues |
16,828 |
11,559 |
|
Gross Profit |
10,582 |
6,815 |
|
Gross Margin |
62.9 % |
59.0 % |
|
Net Loss |
(8,308) |
(10,042) |
|
Working Capital[1] |
119,820 |
153,272 |
|
Cash, Cash Equivalents and Short-Term Deposits[2] |
112,540 |
139,787 |
|
|
(7,611) |
(1,390) |
|
Non-GAAP Financial Data |
|
|
|
Non-GAAP Gross Margin[3] |
66.7 % |
62.0 % |
|
Adjusted EBITDA Loss[4] |
(4,346) |
(7,069) |
|
Non-GAAP Loss Per Share[5] (in |
|
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(
|
Three Months Ended
|
||||
|
2025 |
|
2024 |
||
|
|
|
|
||
REVENUES |
16,828 |
|
11,559 |
||
COST OF REVENUES |
(6,246) |
|
(4,744) |
||
GROSS PROFIT |
10,582 |
|
6,815 |
||
OPERATING EXPENSES: |
|
|
|
||
Research and development expenses |
(10,590) |
|
(10,145) |
||
Sales and marketing expenses |
(5,607) |
|
(4,388) |
||
General and administrative expenses |
(3,667) |
|
(3,571) |
||
Change in earnout liability |
(174) |
|
- |
||
TOTAL OPERATING EXPENSES |
(20,038) |
|
(18,104) |
||
OPERATING LOSS |
(9,456) |
|
(11,289) |
||
Change in fair value of Forfeiture Shares |
- |
|
25 |
||
Financial income, net |
1,238 |
|
1,234 |
||
LOSS BEFORE INCOME TAXES |
(8,218) |
|
(10,030) |
||
INCOME TAXES |
(93) |
|
(17) |
||
LOSS AFTER INCOME TAXES |
(8,311) |
|
(10,047) |
||
Equity in earnings of investee |
3 |
|
5 |
||
NET LOSS |
(8,308) |
|
(10,042) |
||
EARNINGS PER SHARE DATA:
BASIC AND DILUTED NET LOSS PER ORDINARY SHARE[6] (in |
|
|
|
||
WEIGHTED AVERAGE NUMBER OF SHARES USED IN CALCULATION OF NET LOSS PER ORDINARY SHARE |
105,255,959 |
|
104,047,426 |
||
Change in unrealized losses on cash flow hedges |
(542) |
|
- |
||
TOTAL COMPREHENSIVE LOSS |
(8,850) |
|
- |
CONDENSED CONSOLIDATED BALANCE SHEETS
(
ASSETS |
|
|
|
|
||
CURRENT ASSETS Cash and cash equivalents |
|
|
40,997 |
|
|
35,423 |
Short-term deposits |
|
|
71,543 |
|
|
95,532 |
Restricted Short-term deposit |
|
|
1,153 |
|
|
1,138 |
Trade accounts receivable |
|
|
9,551 |
|
|
7,751 |
Inventories |
|
|
10,858 |
|
|
10,155 |
Prepaid expenses and other current assets |
|
|
2,597 |
|
|
3,904 |
TOTAL CURRENT ASSETS |
|
|
136,699 |
|
|
153,903 |
LONG-TERM ASSETS: |
|
|
|
|
|
|
Property and equipment, net |
|
|
3,498 |
|
|
3,555 |
Operating lease right-of-use assets |
|
|
7,253 |
|
|
7,458 |
Intangible assets |
|
|
4,467 |
|
|
4,702 |
|
|
|
1,847 |
|
|
1,847 |
Other assets |
|
|
798 |
|
|
687 |
TOTAL LONG-TERM ASSETS |
|
|
17,863 |
|
|
18,249 |
TOTAL ASSETS |
|
|
154,562 |
|
|
172,152 |
|
|
|
|
|
|
|
LIABILITIES AND EQUITY
CURRENT LIABILITIES |
|
|
16,879 |
|
|
20,326 |
LONG-TERM LIABILITIES |
|
|
|
|
|
|
Forfeiture Shares |
|
|
1 |
|
|
1 |
Non-current operating leases liabilities |
|
|
6,412 |
|
|
6,645 |
Earnout liability |
|
|
2,587 |
|
|
2,413 |
Other long-term liabilities |
|
|
76 |
|
|
79 |
TOTAL LONG-TERM LIABILITIES |
|
|
9,076 |
|
|
9,138 |
TOTAL LIABILITIES |
|
|
25,955 |
|
|
29,464 |
|
|
|
|
|
|
|
TOTAL SHAREHOLDERS' EQUITY |
|
|
128,607 |
|
|
142,688 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
154,562 |
|
|
172,152 |
|
|
|
|
|
|
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(
|
|
Three Months Ended
|
|
||||
|
|
2025 |
2024 |
|
|||
CASH FLOW FROM OPERATING ACTIVITIES |
|
|
|
|
|||
Net loss for the period |
|
(8,308) |
(10,042) |
|
|||
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|||
Income and expense items not involving cash flows: |
|
|
|
|
|||
Depreciation and amortization |
|
770 |
456 |
|
|||
Stock-based compensation |
|
4,166 |
3,764 |
|
|||
Exchange rate differences |
|
140 |
525 |
|
|||
Realized and unrealized losses on non-designated derivative instruments |
|
(204) |
- |
|
|||
Interest on short-term deposits |
|
517 |
275 |
|
|||
Change in fair value of forfeiture shares |
|
- |
(25) |
|
|||
Change in earnout liability |
|
174 |
- |
|
|||
Reduction in the carrying amount of ROU assets |
|
418 |
484 |
|
|||
Equity in earnings of investee, net of dividend received |
|
(3) |
5 |
|
|||
Changes in operating assets and liabilities, net of effects of business acquired: |
|
|
|
|
|||
Trade accounts receivable |
|
(1,800) |
4,735 |
|
|||
Prepaid expenses and other current assets |
|
825 |
207 |
|
|||
Inventories |
|
(762) |
1,347 |
|
|||
Other assets |
|
(115) |
74 |
|
|||
Current Liabilities |
|
(3,196) |
(2,761) |
|
|||
Change in operating lease liabilities |
|
(230) |
(418) |
|
|||
Other long-term liabilities |
|
(3) |
(16) |
|
|||
Net cash used in operating activities |
|
(7,611) |
(1,390) |
|
|||
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|||
Investment in short-term deposits |
|
(30,005) |
(37,840) |
|
|||
Maturities of short-term deposits |
|
53,278 |
56,979 |
|
|||
Purchase of property and equipment |
|
(357) |
(30) |
|
|||
Derivative instruments of non-designated hedges |
|
(265) |
- |
|
|||
Net cash provided by investing activities |
|
22,651 |
19,109 |
|
|||
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|||
Repurchase of Ordinary Shares |
|
(9,585) |
- |
|
|||
Exercise of stock options |
|
188 |
126 |
|
|||
Net cash provided by (used in) financing activities |
|
(9,397) |
126 |
|
|||
|
|
|
|
|
|||
Effect of exchange rate changes on cash and cash equivalents |
|
(69) |
(5) |
|
|||
INCREASE IN CASH AND CASH EQUIVALENTS |
|
5,574 |
17,839 |
|
|||
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD |
|
35,423 |
17,261 |
|
|||
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD |
|
40,997 |
35,100 |
|
|||
|
|
|
|
|
|||
SUPPLEMENT DISCLOSURE OF CASH FLOW INFORMATION |
|
|
|
|
|||
Cash paid for taxes |
|
19 |
35 |
|
|||
|
|
|
|
|
|||
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES |
|
|
|
|
|||
Trade accounts payable on account of property and equipment |
|
62 |
212 |
|
|||
Operating lease liabilities arising from obtaining operating right-of-use assets |
|
213 |
31 |
|
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(
The following table provides a reconciliation of Net loss to Adjusted EBITDA, a non-GAAP measure. Adjusted EBITDA is defined as Net profit (loss) before financial income (expense), net, income taxes, equity in earnings of investee and depreciation and amortization, further adjusted to exclude share-based compensation and change in fair value of Forfeiture Shares and change in earnout liability, which may vary from period-to-period. We caution investors that amounts presented in accordance with our definition of Adjusted EBITDA may not be comparable to similar measures disclosed by other issuers, because not all issuers calculate Adjusted EBITDA in the same manner. Adjusted EBITDA should not be considered as an alternative to Net loss or any other performance measures derived in accordance with GAAP or as an alternative to cash flows from operating activities as a measure of our liquidity.
Although we provide guidance for Adjusted EBITDA, we are not able to provide guidance for projected Net profit (loss), the most directly comparable GAAP measures. Certain elements of Net profit (loss), including share-based compensation expenses and warrant valuations, are not predictable due to the high variability and difficulty of making accurate forecasts. As a result, it is impractical for us to provide guidance on Net profit (loss) or to reconcile our Adjusted EBITDA guidance without unreasonable efforts. Consequently, no disclosure of projected Net profit (loss) is included. For the same reasons, we are unable to address the probable significance of the unavailable information.
|
Three Months Ended
|
||||||
|
2025 |
|
2024 |
||||
|
|
|
|
||||
Net Loss |
(8,308) |
|
(10,042) |
||||
Adjusted to exclude the following: |
|
|
|
||||
|
Change in fair value of Forfeiture Shares |
- |
|
(25) |
|||
|
Change in earnout liability |
174 |
|
- |
|||
|
Financial income, net |
(1,238) |
|
(1,234) |
|||
|
Income taxes |
93 |
|
17 |
|||
|
Equity in earnings of investee |
(3) |
|
(5) |
|||
|
Depreciation |
770 |
|
456 |
|||
|
Stock-based compensation expenses |
4,166 |
|
3,764 |
|||
Adjusted EBITDA Loss |
(4,346) |
|
(7,069) |
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(
The following tables provide a calculation of the GAAP Loss per share and reconciliation to Non-GAAP Loss per share.
|
Three Months Ended
|
||||
GAAP Loss per Share |
2025 |
2024 |
|||
|
|
|
|||
GAAP Net Loss used for computing Loss per Share |
(8,308) |
(10,042) |
|||
Earnings Per Share Data: |
|
|
|||
GAAP Loss per Share (in |
|
|
|||
Weighted average number of shares used in |
105,255,959 |
104,047,426 |
|||
|
Three Months Ended
|
||||
Non-GAAP Loss per Share[7] |
2025 |
2024 |
|||
|
|
|
|||
GAAP Net Loss |
(8,308) |
(10,042) |
|||
Adjusted to exclude the following: |
|
|
|||
Stock based compensation |
4,166 |
3,764 |
|||
Depreciation |
770 |
456 |
|||
Change in fair value of Forfeiture Shares |
- |
(25) |
|||
Change in earnout liability |
174 |
- |
|||
Total Non-GAAP Loss used for computing Loss per Share |
(3,198) |
(5,847) |
|||
Earnings Per Share Data: |
|
|
|||
Non-GAAP Loss per Share (in |
|
|
|||
Weighted average number of shares used in |
105,255,959 |
104,047,426 |
1. Working Capital is calculated as Total Current Assets, less Total Current Liabilities, as of the last day of the period.
2. As of the last day of the period.
3. Non-GAAP Gross Margin is defined as: GAAP Gross Profit excluding share-based compensation and depreciation and amortization expenses, divided by revenue. For the three months ended
4. Adjusted EBITDA is defined as Net profit (loss) before financial income (expense), net, income taxes, equity in earnings of investee, and depreciation and amortization, further adjusted to exclude share-based compensation and change in fair value of Forfeiture Shares and in earnout liability, which may vary from period-to-period. We caution investors that amounts presented in accordance with our definition of Adjusted EBITDA may not be comparable to similar measures disclosed by other issuers, because not all issuers calculate Adjusted EBITDA in the same manner. Adjusted EBITDA should not be considered as an alternative to Net loss or any other performance measures derived in accordance with GAAP or as an alternative to cash flows from operating activities as a measure of our liquidity. Please refer to the appendix at the end of this press release for a reconciliation to the most directly comparable measure in accordance with GAAP.
5. See reconciliation of GAAP to non-GAAP financial measures.
6. See footnote 5.
7. The company calculates its non-GAAP Loss per Share as GAAP Net Loss adjusted to exclude the following: Stock based compensation, depreciation and amortization, and the change in fair value of Forfeiture Share and earnout liability divided by the weighted average number of shares used in calculation of net loss per share.
For more information, please contact:
Investor Relations Manager
michal.benari@valens.com
MS-
msegal@ms-ir.com
Media Contact:
Head of Communications
yoni.dayan@valens.com
Photo - https://mma.prnewswire.com/media/2681398/Valens_Semiconductor_financial_results.jpg
Logo - https://mma.prnewswire.com/media/2309625/Valens_Semiconductor_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/valens-semiconductor-reports-first-quarter-2025-results-302448478.html
SOURCE